Trial
NCT02411643
Molecular Effects of Topical Calcipotriene on Morphea
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
—
Condition
Morphea
Intervention
topical calcipotriene 0.005% ointment
Why stopped
Accrual incomplete/Investigator left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-13